GLMD

GALMED PHARMACEUTICALS LTD

GLMD·M47238148·US·Common Stock·Healthcare - Biotechnology-13D/G

GLMD (GALMED PHARMACEUTICALS LTD) is held by 10 institutional investors as of Q2 2026. Largest holders: CITADEL ADVISORS LLC ($48,315), HRT FINANCIAL LP ($23,000), XTX Topco Ltd ($8,353). Net institutional sentiment: Mixed.

10
Holders
(1 Elite)
$56,760
Total Value
33% (9)
Consensus
3 buying - 6 selling
13F: Insider & Congress: Updated regularly
GLMD

Smart Money Verdict

View all
Loading verdict
Held by 10 funds
1 elite

Who's Trading

Source dates: Price Sep 22, 2026 · Insiders none · Activists Nov 7, 2025 · Congress none

ActivistCICVI Investments, Inc.3.1%Nov 7, 2025

Top Holders

Checking access…
Action
Increased
86,851(+663.1%)$48,3150.0%+445.93%
22
New
42,090$23,0000.0%+551.98%
29
Decreased
15,015(-33.0%)$8,3530.0%+485.81%
0
Decreased
56(-64.3%)$310.0%+199.83%
0
Unchanged
43$240.0%+98.82%
0
Unchanged
14$80.0%-47.16%
0
Unchanged
5$20.0%-47.16%
0
Unchanged
2$20.0%-47.16%
0
Decreased
3(-99.9%)$20.0%+169.82%
0
Exited
0(-100.0%)$8,0580.0%-18.55%
0
Exited
0(-100.0%)$39,2870.0%-36.08%
0
New
550$00.0%+551.98%
17
Exited
0(-100.0%)$2940.0%-25.97%
0
GLMDGLMDGALMED PHARMACEUTICALS LTD

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used